Čeština | Dansk | Deutsch | English | Español | Français | Italiano | Nederlands | Norsk | Polski | Português | Pусский | Suomi | Svenska | US
Euro Huntington's disease network [logo]
EHDN2016 DISEASE NETWORK REGISTRY PROJECTS LOGIN
 
 
  
The Project - Constitution -
--->Uutiset
[-]Projekti
--->Rahoittaja
--->[+]Johtokunta
--->[+]Writing Committee Strategic ...
--->[+]Neuvoa antava lautakunta
--->Keskuskoordinaatio
--->Kielikoordinaatio
--->Fellowship Programme
--->[-]Perustuslaki 2008
--->Article 1
--->Article 2
--->Article 3
--->Article 4
--->Article 5
--->Article 6
--->Article 7
--->Article 8
--->Article 9
--->Article 10
--->Article 11
--->Article 12
--->Documents
--->[+]Äänestys
--->[-]Jäsenet
--->Jäsenyyden hakeminen
[-]Tutkimuspaikat
--->[+]Itävalta
--->[+]Belgia
--->[+]Tsekin tasavalta
--->[+]Tanska
--->[+]Suomi
--->[+]Ranska
--->[-]Saksa
--->Coordination
--->HD Associations
--->Standard of Care
--->Aachen
--->Berlin
--->Bochum
--->Bonn
--->Dresden
--->Dinslaken
--->Düsseldorf
--->Erlangen
--->Freiburg
--->Hamburg
--->Hannover
--->HH-Heiligenhafen
--->Itzehoe
--->Marburg-Uni
--->[+]Lübeck
--->Marburg-KPP
--->Mainz
--->Munich
--->München-LMU
--->Münster
--->Rostock
--->Kontakte
--->Taufkirchen
--->Ulm
--->[+]Würzburg
--->[+]Ireland
--->[+]Italia
--->[-]Alankomaat
--->Coordination
--->HD Associations
--->Enschede
--->Groningen
--->Leiden
--->[+]Maastricht
--->Nijmegen
--->[+]Norja
--->[+]Puola
--->[+]Portugali
--->[+]Russia
--->[+]Espanja
--->[+]Ruotsi
--->[+]Sveitsi
--->[+]Iso-Britannia
--->[+]Outside Europe
[-]Työryhmät
--->[+]Advanced HD
--->[+]Behavioural Phenotype
--->[+]Biological Modifiers
--->[+]Biomarkers
--->[+]Brainbanking
--->[+]Cognitive Phenotype
--->[+]Environmental Modifiers
--->[+]Functional Ability
--->[-]Genetic Testing
--->[+]Dates
--->[+]Meetings
--->[+]Genetic Modifiers
--->[+]Health Economics
--->[+]Imaging
--->[+]Juveniili Huntingtonin tauti
--->[+]Motor Phenotype
--->[+]Neuroprotective Rx
--->[+]Physiotherapy
--->[+]Quality of Life
--->[+]Standard of Care
--->[+]Surgical Therapy
--->[+]Symptomatic Rx
--->[+]Young Adults
[-]Tapahtumat
--->[-]EHDN 2016
--->Announcement
--->Introduction
--->Registration
--->Programme Fri
--->Programme Sat
--->Programme Sun
--->Additional Meetings
--->Floor plan
--->[+]Overduin Registration
--->CME points
--->Sponsoring
--->Travel Information
--->Hotel booking
--->Social activities
--->Reimbursement
--->[+]Abstract Submission
--->Contacts
--->Documents
--->Feedback
--->EHDN 2014
--->Announcement
--->Introduction
--->Registration
--->Programme Fri
--->Programme Sat
--->Programme Sun
--->Additional Meetings
--->CME points
--->Sponsoring
--->Travel Information
--->Hotel Booking
--->Reimbursement
--->Social Activities
--->[+]Abstract Submission
--->Contacts
--->Feedback
--->[+]EHDN 2012
--->[-]EHDN 2010
--->Introduction
--->Programme I
--->Programme II
--->Additional Meetings
--->Registration
--->EHA Programme
--->[+]EHA Registration
--->Plenary Dinner
--->Social Programme
--->Important Dates
--->[+]Abstract Submission
--->Reimbursement
--->Hotel Booking
--->[+]Travel and Location
--->[+]About Prague
--->Documents
--->Committees
--->Contact
--->Feedback & Evaluation
--->[-]EHDN 2008
--->Programme
--->Additional Meetings
--->EHA Programme
--->Social Programme
--->Kids Programme
--->Important Dates
--->Voting
--->Reimbursement
--->[+]Registration
--->[+]Abstract Submission
--->Evaluation & Feedback
--->[+]Travel and Location
--->[+]About Lisbon
--->[+]Documents
--->Committees
--->Contact
--->[+]EHDN 2007
--->[+]EHDN 2006
--->[-]EHDN 2005
--->Final Programme
--->Plenary Dinner
--->Registration
--->Working Groups
--->Meeting Venue
--->Manchester
--->Evaluation & Feedback
--->[+]EHDN 2004
[+]Yhteydenpito
--->Työtarjoukset

THE CONSTITUTION

OF THE

EUROPEAN HUNTINGTON´S DISEASE NETWORK



Table of Contents

ARTICLE 1 NAME; MISSION AND PRINCIPLES
ARTICLE 2 ORGANIZATION
ARTICLE 3 MEMBERSHIP
ARTICLE 4 EXECUTIVE COMMITTEE; CHAIR AND CO-CHAIR
ARTICLE 5 STANDING EHDN COMMITTEES
ARTICLE 6 ADMINISTRATION
ARTICLE 7 MEETINGS OF MEMBERS
ARTICLE 8 EHDN ENDORSEMENT OF PROJECTS
ARTICLE 9 ACCESS TO EHDN DATA AND BIOMATERIALS
ARTICLE 10  PUBLICATION AND AUTHORSHIP
ARTICLE 11 ETHICS AND CONFLICTS-OF-INTEREST
ARTICLE 12 AMENDMENTS; DISSOLUTION; EFFECTIVE DATE
  
about us | privacy statement | disclaimer | terms of use